New study from the Foundation analyses 10 years of data on pharma companies and access to medicine

Amsterdam, the Netherlands, 16 May 2019 - In a new report published today, the Access to Medicine Foundation shows where pharmaceutical companies have made progress in the past ten years when it comes to access to medicine. It analyses companies’ performances in 106 low- and middle-income countries – home to 83% of all people alive today. 

It finds clear evidence of progress, most notably in R&D, and in how companies approach access. A few companies are carrying the greater part of the load. Overall, companies’ activity concentrates on a few diseases and countries.

Get in touch

Back to top |